InvestorsHub Logo
Followers 30
Posts 5071
Boards Moderated 0
Alias Born 01/07/2020

Re: invest2992 post# 285851

Monday, 07/13/2020 5:17:56 PM

Monday, July 13, 2020 5:17:56 PM

Post# of 426721
inv92@ Everything that can DELAY Amarin in 'hitting the market for REAL' - is pulled to the last day possible (or so it sure seems).
-----------------------

September 2018 - big day of R-I release (close to 2 years ago) - everyone thought - Now we are there 'AT Last' (8 years after Vascepa 'first Approved' for high TG)
-------------------------------

What happens for the next 6 months: NOTHING. No one could find out if FDA would require an Adcom or not - for the new Label of Amarin. Then at long last: Adcom in August 2019.

We Waited !

Days before Adcom announced - the meting were postponed to November 2019.

We Waited !

AQdcom 16 to 0 was a victory - but what not many understood at the time - was' - that the delay of Adcom - and later final FDA approval in december ment that result og R-I approval - still not on the label of Vascepa to this day.

JT now talking about 'Patent Trial' on CNBC.

We Waited !

The chock ruling Marts 30 2020. Likely another 8 - 10 months delay' to know where Amarin and Vascepa is going.

Back to Waiting !
-----------------------------

Difficult not to feel that FDA (and BP) is 'paying back' for earlier Amarin trial against FDA - by simply 'eating most of' Amarins 20 years of Patent protection.

Impossible to prove that Adcom delay - was not by accident - and that Patent trial by 2 big Generics was from the start 'just ment as further delaying Amarin' (as many have pointed out - Hikma and Reddy newer expected to win).
-------------------------------

So what are AMRN retailers doing now: SURPRISE:

They are Waiting !

Jasbg
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News